Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last C$0.05 CAD
Change Today 0.00 / 0.00%
Volume 0.0
PYT On Other Exchanges
Symbol
Exchange
Venture
As of 1:34 PM 07/2/15 All times are local (Market data is delayed by at least 15 minutes).

pyng medical corp (PYT) Snapshot

Open
C$0.05
Previous Close
C$0.05
Day High
C$0.05
Day Low
C$0.05
52 Week High
09/3/14 - C$0.07
52 Week Low
11/20/14 - C$0.02
Market Cap
1.1M
Average Volume 10 Days
2.9K
EPS TTM
C$-0.03
Shares Outstanding
23.6M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for PYNG MEDICAL CORP (PYT)

Related News

No related news articles were found.

pyng medical corp (PYT) Related Businessweek News

No Related Businessweek News Found

pyng medical corp (PYT) Details

Pyng Medical Corp., a medical device company, researches, develops, engineers, manufactures, and distributes trauma and resuscitation products for front-line critical care personnel worldwide. Its product portfolio comprises sternal intraosseous, pelvic stabilization, and tourniquet devices. The company’s sternal intraosseous device products include FASTResponder, FASTCombat, and FAST1, which deliver emergency fluids and medications into the vascular system through the bone marrow of the manubrium. Its pelvic stabilization device products comprise T-PODResponder and T-PODCombat that are designed for one person using an easy-to-tighten pulley system. The company’s tourniquet device products include MATResponder and MATCombat, which are designed to provide safe compression in controlled increments of all limbs for blood flow occlusion; and MAT Tourniquet, which is applied by the wounded patient or initial responder to stop life threatening bleeding of any extremity to reduce the risk of limb loss and mortality, as well as E-MAT, a tourniquet for the emergency medical services market. It also provides CRIC (complete rapid illuminated cricothyrotomy), a life-saving medical product allowing for one-handed surgical airway intervention. Pyng Medical Corp. markets its products through a network of distributors to hospital staff, emergency medical services, and military forces. The company is based in Richmond, Canada.

pyng medical corp (PYT) Top Compensated Officers

Chief Executive Officer and President
Total Annual Compensation: C$212.7K
Chief Financial Officer and Corporate Secreta...
Total Annual Compensation: C$139.3K
Compensation as of Fiscal Year 2014.

pyng medical corp (PYT) Key Developments

Pyng Medical Corp. Announces Financial Results for the Second Quarter and Six Months Ended March 31, 2015

Pyng Medical Corp. announced financial results for the second quarter and six months ended March 31, 2015. For the quarter, the company reported total sales of CAD 1,650,528, up 13% compared with CAD 1,466,392 for the second quarter of fiscal 2014. The sales increase was mainly driven by higher TPOD sales resulting from the stronger demand from the international market. The company reported a net loss of CAD 166,064 equal to a loss of CAD 0.007 per share compared to a net loss of CAD 194,870 or loss of CAD 0.008 per share reported one year ago. Earnings before interest, depreciation, amortization and taxes from continuing operations were negative CAD 3,790, a decrease of CAD 25,336 from CAD 21,546 reported for the second quarter of fiscal 2014. For the six months period, total sales of CAD 3,164,603 were recorded, up 5% from CAD 3,003,295 for the comparative period last year.

Pyng Medical Corp., Board Meeting, Apr 22, 2015

Pyng Medical Corp., Board Meeting, Apr 22, 2015. Agenda: To consider management changes.

Pyng Medical Corp. Announces Financial Results for the First Quarter Ended December 31, 2014

Pyng Medical Corp. announced financial results for the first quarter ended December 31, 2014. For the quarter, the company reported total sales of CAD 1,514,075, down 1% compared with CAD 1,536,903 for the comparative quarter last year. The company reported a net loss of CAD 109,042 for this quarter, equal to a loss of CAD 0.005 per share, compared to a net loss of CAD 82,891 or loss of CAD 0.004 per share one year earlier. Earnings before interest, depreciation, amortization and taxes (EBITDA) from continuing operations were CAD 49,739, a decrease of CAD 79,505 from CAD 129,244 reported for the first quarter of fiscal 2014.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PYT:CN C$0.05 CAD 0.00

PYT Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for PYT.
View Industry Companies
 

Industry Analysis

PYT

Industry Average

Valuation PYT Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 0.2x
Price/Book 0.3x
Price/Cash Flow NM Not Meaningful
TEV/Sales NM Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PYNG MEDICAL CORP, please visit www.pyng.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.